Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jansen

Showing results (1231-1240 of 1,250) with videos related to

Pageof 125
Sort By:
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 28, 2017
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological PsychiatryPiotr Lewczuk, Peter Riederer, Sid E O'Bryant, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
Characteristics of subjective cognitive decline associated with amyloid positivityOlin Janssen, Willemijn J Jansen, Stephanie J B Vos, et al.
JAMA|May 20, 2015
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysisRik Ossenkoppele, Willemijn J Jansen, Gil D Rabinovici, et al.
Nature Genetics|May 16, 2006
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitisHeiko Witt, Miklós Sahin-Tóth, Olfert Landt, et al.
Circulation. Cardiovascular Quality and Outcomes|November 19, 2024
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN TrialReinoud E Knops, Jolien A de Veld, Abdul Ghani, et al.
Circulation|November 15, 2021
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN TrialReinoud E Knops, Willeke van der Stuijt, Peter Paul H M Delnoy, et al.
Circulation. Arrhythmia and Electrophysiology|December 3, 2024
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN TrialLouise R A Olde Nordkamp, Shari Pepplinkhuizen, Abdul Ghani, et al.
European Heart Journal|August 28, 2022
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trialReinoud E Knops, Shari Pepplinkhuizen, Peter Paul H M Delnoy, et al.
JAMA|January 6, 2025
Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes: A Randomized Clinical TrialDoortje Rademaker, Leon de Wit, Ruben G Duijnhoven, et al.
Pageof 125

Showing results (1231-1240 of 1,250) with videos related to

Sort By:
Pageof 125
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 28, 2017
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological PsychiatryPiotr Lewczuk, Peter Riederer, Sid E O'Bryant, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
Characteristics of subjective cognitive decline associated with amyloid positivityOlin Janssen, Willemijn J Jansen, Stephanie J B Vos, et al.
JAMA|May 20, 2015
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysisRik Ossenkoppele, Willemijn J Jansen, Gil D Rabinovici, et al.
Nature Genetics|May 16, 2006
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitisHeiko Witt, Miklós Sahin-Tóth, Olfert Landt, et al.
Circulation. Cardiovascular Quality and Outcomes|November 19, 2024
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN TrialReinoud E Knops, Jolien A de Veld, Abdul Ghani, et al.
Circulation|November 15, 2021
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN TrialReinoud E Knops, Willeke van der Stuijt, Peter Paul H M Delnoy, et al.
Circulation. Arrhythmia and Electrophysiology|December 3, 2024
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN TrialLouise R A Olde Nordkamp, Shari Pepplinkhuizen, Abdul Ghani, et al.
European Heart Journal|August 28, 2022
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trialReinoud E Knops, Shari Pepplinkhuizen, Peter Paul H M Delnoy, et al.
JAMA|January 6, 2025
Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes: A Randomized Clinical TrialDoortje Rademaker, Leon de Wit, Ruben G Duijnhoven, et al.
Pageof 125